Evidence map›Paper›PMID 33893158›Full record

ArticleClinical cancer research : an official journal of the American Association for Cancer Research2021

How Accurately does PSMA Inhibitor 18F-DCFPyL-PET-CT Image Prostate Cancer?

Lawrence D True, Delphine L Chen

Abstract readComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical cancer research : an official journal of the American Association for Cancer Research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. The performance ofAsian journal of andrology
    Pooled it
  2. Review
  3. Article
  4. PSMA-basedAmerican journal of nuclear medicine and molecular imaging · 2022
    Article
  5. Short-duration dynamic [EJNMMI research · 2021
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Lawrence D TrueDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington. ltrue@uw.edu dlchen7@uw.edu.
Delphine L ChenDepartment of Radiology, Molecular Imaging, Seattle Cancer Care Alliance, and Nuclear Medicine, University of Washington, Seattle, Washington. ltrue@uw.edu dlchen7@uw.edu.ORCID 0000-0002-0150-5401

Funding

TRANSCRIPTOME AND PROTEOME STRATIFICATION OF PROSTATE ADENOCARCINOMA PHENOTYPESP50CA097186 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI PETER S NELSON · 2002 to 2026
$58.1M
NCI NIH HHS P50 CA097186
6 · The paper itself

Abstract

Current techniques for imaging prostate cancer (CT, MRI, and PET agents

Indexed as

Positron Emission Tomography Computed TomographyProstatic NeoplasmsGallium IsotopesGallium RadioisotopesHumansMalegallium 68 PSMA-11Gallium IsotopesGallium Radioisotopes

Identifiers

PMID33893158
PMCPMC8254752

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.